Twenty-eight-day follow-up of patch test reactions to p-phenylenediamine and p-phenylenediamine dihydrochloride: A multicentre study on behalf of the European Environmental and Contact Dermatitis Research Group.

PPD active sensitization allergic contact dermatitis contact allergy delayed dilution series false-negative reactions hypersensitivity late-appearing patch test reactions

Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 11 11 2018
revised: 20 01 2019
accepted: 23 01 2019
pubmed: 27 1 2019
medline: 24 12 2019
entrez: 27 1 2019
Statut: ppublish

Résumé

There is an ongoing discussion on whether routinely patch testing with p-phenylenediamine (PPD) 1.0% pet. is safe, owing to the risk of patch test sensitization. Late-appearing patch test reactions may reflect patch test sensitization, but may also be attributable to a low degree of pre-existing sensitization. To follow the positive patch test reactions to PPD and its salt PPD dihydrochloride (PPD-DHC) in order to characterize reaction patterns concerning time and dose in PPD-sensitized individuals. Volunteers with previous reactions to PPD 1.0% were included and patch tested with PPD and PPD-DHC in equimolar dilution series. There were then seven follow-up visits over a period of 28 days. Twenty-six volunteers completed the study, of whom 23 of 26 (88%) reacted to PPD 1.0%, and 69% reacted to PPD 0.32%. Altogether, 42% and 27% reacted to the corresponding equimolar concentrations of PPD-DHC. After day 7, no new reactions were observed to any concentration tested, either of PPD or of PPD-DHC. No late-appearing reactions to PPD or PPD-DHC were observed at any dose. There is a risk of missing contact allergy when the dose is decreased.

Sections du résumé

BACKGROUND BACKGROUND
There is an ongoing discussion on whether routinely patch testing with p-phenylenediamine (PPD) 1.0% pet. is safe, owing to the risk of patch test sensitization. Late-appearing patch test reactions may reflect patch test sensitization, but may also be attributable to a low degree of pre-existing sensitization.
OBJECTIVES OBJECTIVE
To follow the positive patch test reactions to PPD and its salt PPD dihydrochloride (PPD-DHC) in order to characterize reaction patterns concerning time and dose in PPD-sensitized individuals.
METHODS METHODS
Volunteers with previous reactions to PPD 1.0% were included and patch tested with PPD and PPD-DHC in equimolar dilution series. There were then seven follow-up visits over a period of 28 days.
RESULTS RESULTS
Twenty-six volunteers completed the study, of whom 23 of 26 (88%) reacted to PPD 1.0%, and 69% reacted to PPD 0.32%. Altogether, 42% and 27% reacted to the corresponding equimolar concentrations of PPD-DHC. After day 7, no new reactions were observed to any concentration tested, either of PPD or of PPD-DHC.
CONCLUSION CONCLUSIONS
No late-appearing reactions to PPD or PPD-DHC were observed at any dose. There is a risk of missing contact allergy when the dose is decreased.

Identifiants

pubmed: 30684277
doi: 10.1111/cod.13235
doi:

Substances chimiques

Coloring Agents 0
Phenylenediamines 0
4-phenylenediamine U770QIT64J

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Ewa Young (E)

Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.

Klaus E Andersen (KE)

Department of Dermatology and Allergy Centre, Odense University Hospital, and Dermatological Investigations Scandinavia, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

Magnus Bruze (M)

Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.

Ana Giménez-Arnau (A)

Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma, Barcelona, Spain.

Katrine Ross-Hansen (K)

National Allergy Research Centre, Department of Dermatology and Allergy, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

Jeanne D Johansen (JD)

National Allergy Research Centre, Department of Dermatology and Allergy, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

Jakob Torp Madsen (JT)

Department of Dermatology and Allergy Centre, Odense University Hospital, and Dermatological Investigations Scandinavia, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

Erik Zimerson (E)

Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.

Cecilia Svedman (C)

Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH